Non-Interventional Study Of Celsentri In Treatment Experienced Patients Infected With CCR5 Tropic HIV-1.

Trial Profile

Non-Interventional Study Of Celsentri In Treatment Experienced Patients Infected With CCR5 Tropic HIV-1.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2012

At a glance

  • Drugs Maraviroc (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms CELTROP
  • Sponsors Pfizer; ViiV Healthcare
  • Most Recent Events

    • 07 Jul 2012 Actual patient number changed from 63 to 79 as reported by ClinicalTrials.gov record.
    • 18 Jan 2012 Actual patient number changed from 150 to 63 as reported by ClinicalTrials.gov.
    • 18 Jan 2012 Actual end date changed from Mar 2010 to Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top